|
RWDD4A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.482400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.041800E-01 |
| Normal-vs-Stage2 |
6.548400E-01 |
| Normal-vs-Stage3 |
4.611400E-01 |
| Normal-vs-Stage4 |
7.590400E-01 |
| Stage1-vs-Stage2 |
4.463200E-01 |
| Stage1-vs-Stage3 |
5.923400E-01 |
| Stage1-vs-Stage4 |
8.917200E-01 |
| Stage2-vs-Stage3 |
3.792800E-01 |
| Stage2-vs-Stage4 |
5.903000E-01 |
| Stage3-vs-Stage4 |
8.654400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.388600E-01 |
| Normal-vs-AfricanAmerican |
7.808000E-01 |
| Normal-vs-Asian |
5.528200E-01 |
| Caucasian-vs-AfricanAmerican |
5.013400E-01 |
| Caucasian-vs-Asian |
4.728400E-01 |
| AfricanAmerican-vs-Asian |
4.607000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.477600E-01 |
| Normal-vs-Female |
4.313200E-01 |
| Male-vs-Female |
4.484200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.352800E-01 |
| Normal-vs-Extreme_Weight |
4.579400E-01 |
| Normal-vs-Obese |
5.313600E-01 |
| Normal-vs-Extreme_Obese |
4.120000E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.021000E-01 |
| Normal_Weight-vs-Obese |
8.989400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.187700E-02 |
| Extreme_Weight-vs-Obese |
9.906200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.130400E-02 |
| Obese-vs-Extreme_Obese |
3.971800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.822410E-01 |
| Normal-vs-Age(41-60Yrs) |
6.301800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.034400E-01 |
| Normal-vs-Age(81-100Yrs) |
7.695400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.675580E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.919800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.551400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.044000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.500600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.332800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.090800E-01 |
| Normal-VS-Type2 PRCC |
2.405600E-01 |
| Normal-VS-KIRP CIMP |
7.998600E-04 |
| Normal-VS-Unclassified PRCC |
7.157000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.618400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.018570E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.052200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.471900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.995400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.198200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.687800E-02 |
| Normal-vs-N1 |
7.554000E-01 |
| Normal-vs-N2 |
1.082990E-03 |
| N0-vs-N1 |
5.891200E-01 |
| N0-vs-N2 |
1.767620E-01 |
| N1-vs-N2 |
2.910800E-01 |
|
|
